Loading...
StocksRunner logo
 
 
Anterix
32.60
+0.77%
 
ATEX Anterix
Last Price
Change
32.60
 
+0.77%
 
 
 

 
Sentiment
 
  Login to display
 
 

33.63

29.31

36.91

41.73

 
 
1m
3m
6m
1y
 

Summary

Anterix (ATEX) still has no score becuse there is not enough information which allows us to analyze the activity of the stock over a period of time
 

Strengths

Rewards

 Upgraded on attractively valued

Rewards

 Earnings are forecast to grow

 
 

Risk Level

 
StocksRunner
 

Anterix (ATEX) has High Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

3.00
 

StocksRunner

 Reported a weak earnings

StocksRunner

 Above analyst estimates

 
 

Rating

×
 

Rating

5.00
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

3.00
 
 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

5.00
 

StocksRunner

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is positive and also has improved from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
71%
100%
0%
100%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
71%
14%
Positive
Negative
5 out of 7
events present
1 out of 7
events present
 

 
Events Calendar
Click for more information
 
May
S
M
T
W
T
F
S
June
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Upgrade
1 Week Ago
32.61
-0.76%
 
Strong Earnings
3 Weeks Ago
32.30
+1.91%
 
Options Activity
2 Month Ago
31.50
-2.02%
 
Top Headlines

goldman sachs upgrades quanterix (qtrx). fintel reports that on may 23 2023 goldman sachs upgraded their outlook for quanterix (nasdaq:qtrx) from neutral to buy .

Tue May 23, 2023

Rating

goldman sachs turns ish on biotech with significant opportunity. shares of ) spiked in early trading on tuesdayand the stock is up . quanterix is a pure play on the neurology diagnostics market and has a &ldquo.leading highly sensitive ip-protected techn

Tue May 23, 2023

Potential

quanterix corporation (qtrx) reports q1 loss tops revenue estimates. quanterix corporation (qtrx) came out with a quarterly loss of $0.16 per share versus the zacks consensus estimate of a loss of $0.36. this compares to loss of $0.49

Tue May 9, 2023

Earnings
Earnings

noteworthy tuesday option activity: atex lmt ash. looking at options trading activity among components of the russell 3000 index there is noteworthy activity today in anterix inc (symbol: atex) where a total volume of 474 contracts has been

Tue May 2, 2023

Momentum

lower colorado river authority expands its communication capabilities with new 900 mhz private wireless network from anterix. texas entity becomes first non-investor owned utility to build a 900 mhz broadband network  

Mon Apr 24, 2023

Activity

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our daily ATEX alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
StocksRunner

StocksRunner

Get the pulse of the market

 
StocksRunner

ATEX Anterix

Last Price
32.60
Change
+0.77%
 

Summary

Anterix (ATEX) still has no score becuse there is not enough information which allows us to analyze the activity of the stock over a period of time

 
 
33.63
29.31
36.91
41.73
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Strengths

Rewards

 Upgraded on attractively valued

Rewards

 Earnings are forecast to grow

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
100%
0%
100%
On Track
On Track
On Track
 
71%
14%
Positive
Negative
5 out of 7
events present
1 out of 7
events present
 

Street Opinion

Street view is bullish and have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 

Earnings

×
 

Earnings

3.00
 

StocksRunner

 Reported a weak earnings

StocksRunner

 Above analyst estimates

 
 

Rating

×
 

Rating

5.00
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

3.00
 
 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

5.00
 

StocksRunner

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is positive and also has improved from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
StocksRunner
 

Anterix (ATEX) has High Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
May
 
S
M
T
W
T
F
S
 
June
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Upgrade
1 Week Ago
32.61
-0.76%
 
Strong Earnings
3 Weeks Ago
32.30
+1.91%
 
Options Activity
2 Month Ago
31.50
-2.02%
 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our daily ATEX Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines